Advertisement

The impact of cereal grain consumption on the development and severity of non-alcoholic fatty liver disease

Abstract

Purpose

There is evidence that dietary habits contribute to the presence and severity of non-alcoholic fatty liver disease (NAFLD). The aim of the present study was to explore any associations between consumption of grains and the development and severity of NAFLD.

Methods

Seventy-three consecutive NAFLD patients were enrolled. Additionally, 58 controls matched for age, sex and body mass index with 58 patients were also included. Consumption of grains was estimated through a semi-quantitative food frequency questionnaire. Medical history, anthropometric indices, body composition analysis, physical activity data, biochemical and inflammatory markers were available for all the participants. Liver stiffness measurement by transient elastography was performed in 58 and liver biopsy in 34 patients.

Results

In patients, consumption of whole grains was associated with lower abdominal fat level (β = −0.24, p = 0.02) and lower levels of insulin resistance index (β = −0.28, p = 0.009), while it also correlated inversely with interleukin-6 levels (ρ = −0.23, p = 0.05). Consumption of whole grains was associated with lower likelihood of having histological steatohepatitis (OR 0.97, 95 % CI 0.94–1.000), after adjusting for sex and energy intake, but the association became weaker after further adjusting for abdominal fat or interleukin-6 levels. In the case–control analysis, consumption of refined grains was associated with higher odds of having NAFLD (OR 1.021, 95 % CI 1.001–1.042), after adjusting for age, sex, energy intake, abdominal fat level, HOMA-IR, LDL, adiponectin and TNF-α.

Conclusions

Although refined grain consumption increased the likelihood of having NAFLD, whole-grain consumption favorably affected clinical characteristics of patients with NAFLD and tended to be associated with less severe disease.

This is a preview of subscription content, log in to check access.

Access options

Buy single article

Instant unlimited access to the full article PDF.

US$ 39.95

Price includes VAT for USA

Subscribe to journal

Immediate online access to all issues from 2019. Subscription will auto renew annually.

US$ 199

This is the net price. Taxes to be calculated in checkout.

References

  1. 1.

    Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ (2012) The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 142:1592–1609. doi:10.1053/j.gastro.2012.04.001

  2. 2.

    Levene AP, Goldin RD (2012) The epidemiology, pathogenesis and histopathology of fatty liver disease. Histopathology 61:141–152. doi:10.1111/j.1365-2559.2011.04145.x

  3. 3.

    Tsochatzis E, Papatheodoridis GV, Archimandritis AJ (2006) The evolving role of leptin and adiponectin in chronic liver diseases. Am J Gastroenterol 101:2629–2640. doi:10.1111/j.1572-0241.2006.00848.x

  4. 4.

    Tsochatzis EA, Manolakopoulos S, Papatheodoridis GV, Archimandritis AJ (2009) Insulin resistance and metabolic syndrome in chronic liver diseases: old entities with new implications. Scand J Gastroenterol 44:6–14. doi:10.1080/00365520802273058

  5. 5.

    Vernon G, Baranova A, Younossi ZM (2011) Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 34:274–285. doi:10.1111/j.1365-2036.2011.04724.x

  6. 6.

    Sullivan S (2010) Implications of diet on nonalcoholic fatty liver disease. Curr Opin Gastroenterol 26:160–164. doi:10.1097/MOG.0b013e3283358a58

  7. 7.

    Mouzaki M, Allard JP (2012) The role of nutrients in the development, progression, and treatment of nonalcoholic fatty liver disease. J Clin Gastroenterol 46:457–467. doi:10.1097/MCG.0b013e31824cf51e

  8. 8.

    Williams PG (2012) Evaluation of the evidence between consumption of refined grains and health outcomes. Nutr Rev 70:80–99. doi:10.1111/j.1753-4887.2011.00452.x

  9. 9.

    Lefevre M, Jonnalagadda S (2012) Effect of whole grains on markers of subclinical inflammation. Nutr Rev 70:387–396. doi:10.1111/j.1753-4887.2012.00487.x

  10. 10.

    Ye EQ, Chacko SA, Chou EL, Kugizaki M, Liu S (2012) Greater whole-grain intake is associated with lower risk of type 2 diabetes, cardiovascular disease, and weight gain. J Nutr 142:1304–1313. doi:10.3945/jn.111.155325

  11. 11.

    Ross AB, Godin JP, Minehira K, Kirwan JP (2013) Increasing whole grain intake as part of prevention and treatment of nonalcoholic Fatty liver disease. Int J Endocrinol 2013:585876. doi:10.1155/2013/585876

  12. 12.

    World Medical Association declaration of Helsinki (1997) Recommendations guiding physicians in biomedical research involving human subjects. JAMA, J Am Med Assoc 277:925–926

  13. 13.

    Goulet J, Nadeau G, Lapointe A, Lamarche B, Lemieux S (2004) Validity and reproducibility of an interviewer-administered food frequency questionnaire for healthy French-Canadian men and women. Nutr J 3:13. doi:10.1186/1475-2891-3-13

  14. 14.

    Trichopoulou A, Lagiou P (1999) Dietary guidelines for adults in Greece. Arch Hell Med 16:516–524

  15. 15.

    Nanos GD, Gerasopoulos DG (2001) Fruits, Vegetable, Legumes and Grains. In: Zampelas A, Stavrinos V, Wolinsky I, Matalas AL (eds) The mediterranean diet: constituents and health promotion. CRC Press LLC, Boca Raton

  16. 16.

    Manios Y, Moschonis G, Koutsikas K, Papoutsou S, Petraki I, Bellou E, Naoumi A, Kostea S, Tanagra S (2009) Changes in body composition following a dietary and lifestyle intervention trial: the postmenopausal health study. Maturitas 62:58–65. doi:10.1016/j.maturitas.2008.11.005

  17. 17.

    Browning LM, Mugridge O, Chatfield MD, Dixon AK, Aitken SW, Joubert I, Prentice AM, Jebb SA (2010) Validity of a new abdominal bioelectrical impedance device to measure abdominal and visceral fat: comparison with MRI. Obesity (Silver Spring) 18:2385–2391. doi:10.1038/oby.2010.71

  18. 18.

    Friedewald WT, Levy RIFD (1972) Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502

  19. 19.

    Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419

  20. 20.

    Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR (1999) Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94:2467–2474. doi:10.1111/j.1572-0241.1999.01377.x

  21. 21.

    Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41:1313–1321. doi:10.1002/hep.20701

  22. 22.

    Shi L, Liu ZW, Li Y, Gong C, Zhang H, Song LJ, Huang CY, Li M (2012) The prevalence of nonalcoholic fatty liver disease and its association with lifestyle/dietary habits among university faculty and staff in Chengdu. Biomed Environ Sci 25:383–391. doi:10.3967/0895-3988.2012.04.002

  23. 23.

    Toshimitsu K, Matsuura B, Ohkubo I, Niiya T, Furukawa S, Hiasa Y, Kawamura M, Ebihara K, Onji M (2007) Dietary habits and nutrient intake in non-alcoholic steatohepatitis. Nutrition 23:46–52. doi:10.1016/j.nut.2006.09.004

  24. 24.

    Liu S (2002) Intake of refined carbohydrates and whole grain foods in relation to risk of type 2 diabetes mellitus and coronary heart disease. J Am Coll Nutr 21:298–306

  25. 25.

    Giugliano D, Ceriello A, Esposito K (2006) The effects of diet on inflammation: emphasis on the metabolic syndrome. J Am Coll Cardiol 48:677–685. doi:10.1016/j.jacc.2006.03.052

  26. 26.

    Krawczyk M, Bonfrate L, Portincasa P (2010) Nonalcoholic fatty liver disease. Best Pract Res Clin Gastroenterol 24:695–708. doi:10.1016/j.bpg.2010.08.005

  27. 27.

    Wirström T, Hilding A, Gu HF, Östenson C-G, Björklund A (2013) Consumption of whole grain reduces risk of deteriorating glucose tolerance, including progression to prediabetes. Am J Clin Nutr 97:179–187. doi:10.3945/ajcn.112.045583

  28. 28.

    Murtaugh MA, Jacobs DR Jr, Jacob B, Steffen LM, Marquart L (2003) Epidemiological support for the protection of whole grains against diabetes. Proc Nutr Soc 62:143–149

  29. 29.

    Sahyoun NR, Jacques PF, Zhang XL, Juan W, McKeown NM (2006) Whole-grain intake is inversely associated with the metabolic syndrome and mortality in older adults. Am J Clin Nutr 83:124–131

  30. 30.

    McKeown NM, Troy LM, Jacques PF, Hoffmann U, O’Donnell CJ, Fox CS (2010) Whole- and refined-grain intakes are differentially associated with abdominal visceral and subcutaneous adiposity in healthy adults: the Framingham Heart Study. Am J Clin Nutr 92:1165–1171. doi:10.3945/ajcn.2009.29106

  31. 31.

    Liu S, Willett WC, Manson JE, Hu FB, Rosner B, Colditz G (2003) Relation between changes in intakes of dietary fiber and grain products and changes in weight and development of obesity among middle-aged women. Am J Clin Nutr 78:920–927

  32. 32.

    McKeown NM, Yoshida M, Shea MK, Jacques PF, Lichtenstein AH, Rogers G, Booth SL, Saltzman E (2009) Whole-grain intake and cereal fiber are associated with lower abdominal adiposity in older adults. J Nutr 139:1950–1955. doi:10.3945/jn.108.103762

  33. 33.

    Fardet A (2010) New hypotheses for the health-protective mechanisms of whole-grain cereals: what is beyond fibre? Nutr Res Rev 23:65–134. doi:10.1017/S0954422410000041

  34. 34.

    Salas-Salvado J, Martinez-Gonzalez MA, Bullo M, Ros E (2011) The role of diet in the prevention of type 2 diabetes. Nutr Metab Cardiovasc Dis 21(Suppl 2):B32–B48. doi:10.1016/j.numecd.2011.03.009

  35. 35.

    Tilg H, Moschen AR (2008) Insulin resistance, inflammation, and non-alcoholic fatty liver disease. Trends Endocrinol Metab 19:371–379. doi:10.1016/j.tem.2008.08.005

  36. 36.

    Lutsey PL, Jacobs DR Jr, Kori S, Mayer-Davis E, Shea S, Steffen LM, Szklo M, Tracy R (2007) Whole grain intake and its cross-sectional association with obesity, insulin resistance, inflammation, diabetes and subclinical CVD: the MESA Study. Br J Nutr 98:397–405. doi:10.1017/S0007114507700715

  37. 37.

    Nettleton JA, Steffen LM, Mayer-Davis EJ, Jenny NS, Jiang R, Herrington DM, Jacobs DR Jr (2006) Dietary patterns are associated with biochemical markers of inflammation and endothelial activation in the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr 83:1369–1379

  38. 38.

    Yannakoulia M, Yiannakouris N, Melistas L, Kontogianni MD, Malagaris I, Mantzoros CS (2008) A dietary pattern characterized by high consumption of whole-grain cereals and low-fat dairy products and low consumption of refined cereals is positively associated with plasma adiponectin levels in healthy women. Metabolism 57:824–830. doi:10.1016/j.metabol.2008.01.027

Download references

Acknowledgments

We would like to thank Prof. Mary Yannakoulia for her valuable comments during the writing of the manuscript. This research was supported financially by a research grant from the Hellenic Foundation of Gastroenterology & Nutrition.

Conflict of interest

All authors declare no conflicts of interest.

Author information

Correspondence to Meropi D. Kontogianni.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Georgoulis, M., Kontogianni, M.D., Tileli, N. et al. The impact of cereal grain consumption on the development and severity of non-alcoholic fatty liver disease. Eur J Nutr 53, 1727–1735 (2014). https://doi.org/10.1007/s00394-014-0679-y

Download citation

Keywords

  • Non-alcoholic fatty liver
  • Cereals
  • Inflammation
  • Insulin resistance
  • Case–control